BaiYiHuiXin Submits IPO Prospectus for DetecMicro® Vascular Interventional Surgery Planning Software

With the continuous advancement of medical standards, clinical treatment methods are gradually shifting from traditional high-trauma therapies toMinimally Invasive Therapydevelopment, especially inCardiovascular and Cerebrovascular Diseasesparticularly prominent among therapeutic technologies. However, the rapid development of various innovative treatment technologies has been accompanied by inadequate tools and inconsistent understanding, leading to a lack of consistency in disease diagnosis and treatment, as well as instability in quality control.

How to Ensure Standardization in the Diagnosis and Treatment of Cardiovascular and Cerebrovascular Diseaseshas become the shared goal of the entire industry, while the lack of industry standards and evaluation tools has emerged as a critical issue. With the encouragement and support of numerous frontline clinical experts,Boea WisdomContinuously challenging the bottlenecks of technological and interdisciplinary knowledge barriers,Solid"China's first surgical planning software integrating structural analysis and treatment selection has been launched."

In November last year, DetecMicro®, the vascular interventional surgery planning software independently developed by Boea Wisdom (Hangzhou) Network Technology Co., Ltd. (hereinafter referred to as “Boea Wisdom”), officially received approval for Class III domestic medical device registration from the National Medical Products Administration (NMPA) (Registration No.: Guo Xie Zhu Zhun 20233211596).

On Friday, April 19, at 19:30, the 56th session of VCBeat Select New Product Review invitesQian Peidong, CEO & Marketing Director of Boea Wisdom; Zhang Haonan, Product Director & Medical Product Design Expert at Boea Wisdom,Cui Wanpeng, Commercial Director of the Medical Device Division, Huadong Medicine (China)，BringDetecMicro® Vascular Interventional Surgery Planning SoftwareProduct Sharing.

Figure: DetecMicro® by Boea Wisdom Operation Interface

This software employs mature and reliable graphic image algorithms to analyze patients' vascular structures based on their imaging data.High-fidelity reconstruction, providing morphological parameters such as dimensions and angles, providing an important reference for clinicians to formulate surgical plans and improve diagnostic and treatment decisions.

Compared to traditional two-dimensional measurements, DetecMicro®Automated 3D Measurement Capable, which not only saves clinicians a significant amount of measurement time but also proposes personalized treatment plans tailored to the specific characteristics of the patient’s lesions.

After importing imaging data, this software can20 secondsAutomatically generate 3D vascular models internally, in1 MinuteComplete the template measurement for the corresponding surgical procedure within , providing more than20 Itemsbasic preoperative planning information and generate visualized reports with text and images, meeting the needs of most clinical scenarios for preoperative planning and postoperative follow-up. In addition, DetecMicro®’s intelligent workflow assistant standardizes the preoperative planning process, enhances ease of use, significantly reduces the learning curve for physicians, and improves both efficiency and quality.

DetecMirco® leverages medical imaging data to perform refined analysis and interpretation of patients' cardiovascular diseases, providing comprehensive assistance to clinicians in planning interventional procedures, including EVAR, TEVAR, and TAVI.

Automated Template Measurement

Automated Branch Localization

2-Minute Report Generation

Intelligent Midline Generation

Intelligent Calcification Removal

Orthogonal Cross-Sectional Measurement

Intelligent Access Evaluation

Stent Deployment Simulation Assessment

Identification of Relative Positions of Branch Vessels

Virtual Endoscopy

Intuitive Perspective View

More Module Expansion

Scan the QR code on the poster to add the assistant and reserve a spot for the live broadcast.

Qian Peidong

Boea Wisdom CEO & Marketing Director

Responsible for the company’s overall strategic planning and business development, with extensive experience in corporate operations and market management. Possesses familiarity with advanced domestic and international technologies and holds deep understanding and insights into the medical technology sector.

Zhang Haonan

Boea Wisdom Product Director, Medical Product Design Expert

Responsible for the R&D and management of company products, with many years of experience in developing medical software in the field of pan-vascular intervention. Led the team to achieve product innovation and breakthroughs, driving strategic planning and iterative upgrades of products.

Cui Wanpeng

Zhongmei Huadong, Commercial Director of the Medical Device Division

National Business Manager, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., upholding the corporate philosophy of “Serving Public Health” and striving to advance the strategies of innovative transformation and international development.

With 20 years of experience in the medical device industry, possessing extensive practical expertise in sales, government procurement, investment promotion, and channel management.

Boea Wisdom (Hangzhou) Network Technology Co., Ltd. is a technology provider specializing in the integration of engineering simulation technologies with clinical medicine. Pioneering novel non-invasive methods for in vivo tissue assessment, the company possesses core technological reserves and independent intellectual property rights, ushering in a new era of innovative, integrated smart healthcare solutions.

Our mission is to stand at the forefront of digital transformation in the healthcare industry, leveraging robust and leading-edge underlying technologies to make precision medicine accessible to the general public. In the future, we will build a comprehensive digital twin platform for human health, covering the full lifecycle and entire ecosystem, tailored for key stakeholders in the healthcare sector.

“Artery Select New Product Showcase” is a live-streaming program under “Artery Select” dedicated to supporting medical enterprises in launching innovative products. The program’s mission is: to empower the milestone launch of every medical innovation product.

Scan the QR code below to contact the assistant and schedule a live stream.

(If already added, please proactively contact the assistant)